Tsuneji Suzuki

1.5k citations
18 papers · 1.3k indexed · 1 hit paper · h-index 10
Topics
Drug Transport and Resistance Mechanisms (5 papers)Cancer therapeutics and mechanisms (5 papers)Microbial Natural Products and Biosynthesis (3 papers)
Partner nations
JapanGermany

In The Last Decade

Tsuneji Suzuki

18 papers receiving 1.2k citations

Hit Papers

A synthetic inhibitor of histone deacetylase, MS-27-275, ...19992026200820171999200400600

Peers

Tsuneji Suzuki
Comparison fields: 5 of 86
  • Molecular Biology 995
  • Oncology 353
  • Organic Chemistry 302
  • Physiology 93
  • Pharmacology 62
Replace Jana A. Lewis with:
Jana A. Lewis United States
Jaroslav Veselý Czechia
Alexandre A. Pletnev United States
Nadim Jessani United States
Hariprasad Vankayalapati United States
Michael K. Schwaebe United States
Daniel P. Getman United States
Daniel Delorme Canada
Prasun K. Chakravarty United States
Valeria La Pietra Italy
Tsuneji Suzuki relative to Jana A. Lewis United States Jana A. Lewis's profile →
Citations per field
00.5×2.7×
Jana A. Lewis · 1×
Citations per year

Countries citing papers authored by Tsuneji Suzuki

Since Specialization
Citations

This map shows the geographic impact of Tsuneji Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsuneji Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsuneji Suzuki more than expected).

Fields of papers citing papers by Tsuneji Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsuneji Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsuneji Suzuki. The network helps show where Tsuneji Suzuki may publish in the future.

Co-authorship network of co-authors of Tsuneji Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Tsuneji Suzuki. A scholar is included among the top collaborators of Tsuneji Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsuneji Suzuki. Tsuneji Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 8
2 1
3 1
4
Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991.
114
5 235
6 7
7
A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumorsbreakdown →
602
8 81
9 55
10 1
11
Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073.
39
12 21
13 53
14 9
15 4
16 6
17 4
18 49

About Tsuneji Suzuki

Tsuneji Suzuki is a scholar working on Toxicology, Pharmacology and Oncology, having authored 18 papers that have together received 1.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Cancer therapeutics and mechanisms (5 papers) and Microbial Natural Products and Biosynthesis (3 papers). The work is most often cited by research in Molecular Biology (995 citations), Oncology (353 citations) and Organic Chemistry (302 citations). Tsuneji Suzuki has collaborated with scholars based in Japan and Germany. Frequent co-authors include Takashi Tsuruo, Osamu Nakanishi, Akiko Saito, Tomoyuki Ando, Takashi Yamashita, Nobuyuki Fukazawa, Wakao Sato, Masanori Yamaura, Juji Yoshimura and Hironobu Hashimoto. Their work appears in journals such as Proceedings of the National Academy of Sciences, ACS Applied Materials & Interfaces and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026